Lipids detected by brain MRS during coma caused by carnitine palmitoyltransferase 1 deficiency
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Prolonged coma without hypoglycemia or hyperammonemia is a diagnostic challenge. We report brain proton MR spectroscopy (1H MRS) findings in an infant with unexplained coma as the first manifestation of carnitine palmitoyltransferase (CPT) 1 deficiency.
Case report.
An 11-month-old girl became pale and floppy after an 11-hour fast. On admission, she was somnolent but could be awakened. The liver was 2 cm below the right costal margin. She had metabolic acidosis (pH 7.28, Pco2 4.7, base excess −5.8, Hco3 19) and slightly elevated alanine aminotransferase (ALT) 46 U/L (normal <40 U/L). Blood glucose and lactate, plasma ammonia, CSF analysis, and brain 1.5 T MRI were normal.
Despite IV glucose infusion (3 to 4 g/kg/day), her consciousness fluctuated from wakefulness to a sleep-like state, which deepened to coma. On day 6, brain MRI was again normal, whereas 1H MRS (figure) revealed a very high N-acetyl aspartate (NAA)/choline (Cho) ratio for age, excess of glutamate/glutamine, and large lipid peaks in the thalamus, white matter, and cortex.1 EEG showed background slowing with high delta waves without epileptiformic activity. Plasma ammonia fluctuated from 155 to 60 to 102 μmol/L (normal <50 μmol/L) and ALT increased to 160 U/L. She became icteric …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Resident and Fellow Section
Child Neurology: Recurrent rhabdomyolysis due to a fatty acid oxidation disorderGaetano Terrone, Margherita Ruoppolo, Nicola Brunetti-Pierri et al.Neurology, December 30, 2013 -
Expedited Publication
AdrenoleukodystrophyIncreased plasma content of saturated very long chain fatty acidsHugo W. Moser, Ann B. Moser, Karen K. Frayer et al.Neurology, August 01, 1998 -
Article
Bezafibrate in skeletal muscle fatty acid oxidation disordersA randomized clinical trialMette Cathrine Ørngreen, Karen Lindhardt Madsen, Nicolai Preisler et al.Neurology, January 22, 2014 -
Articles
Carnitine palmitoyltransferase II deficiencySuccessful anaplerotic diet therapyC. R. Roe, B-Z Yang, H. Brunengraber et al.Neurology, July 21, 2008